Print This Page
Share this page: More

Syncria Heart Failure Study

Summary of Trial: A multi-center, placebo-controlled, study to evaluate the safety of GSK716155 and its effects on myocardial metabolism, myocardial function and exercise capacity in patients with NYHA Class II/III congestive heart failure.

PI: Dr. Stuart Russell

If interested, please call 410-955-5708 or email Dr. Russell at